BPG is committed to discovery and dissemination of knowledge
Editorial Board
Dr. Qi Rongfeng is a Chief Physician and Associate Professor in the Department of Medical Imaging at Nanjing Drum Tower Hospital, where he also serves as the Research Secretary. He holds an M.D. and Ph.D., and completed postdoctoral training. He is a high‑level talent recruited by Nanjing Drum Tower Hospital. Dr. Qi is the Deputy Director of the Nanjing University Institute of Medical Imaging and Artificial Intelligence. He was a visiting scholar at the University of Southern California, USA, and serves as a master' s supervisor at Nanjing University, Southern Medical University, Nanjing Medical University, Nanjing University of Chinese Medicine, Xuzhou Medical University, and Jiangsu University. Dr. Qi is recognized as a distinguished talent under the Jiangsu "333" High‑Level Talent Program and a Jiangsu Young Medical Talent. He serves as a reviewer for multiple journals, including Biological Psychology ,European Radiology, General Psychiatry,Journal of Affective Disorders, Medical Research and War Trauma, and Journal of Shandong University. He is a Youth Editorial Board Member for Biomedical Engineering and Clinical Medicine and Chinese Journal of CT and MRI, and a Guest Editor for Frontiers in Psychiatry and Frontiers in Human Neuroscience. He is also a peer reviewer for the National Natural Science Foundation of China (NSFC). With over 10 years of experience in diagnostic imaging, Dr. Qi specializes in neuroradiology and musculoskeletal imaging. His research focuses on the clinical application of multimodal neuroimaging techniques in post‑traumatic stress disorder (PTSD), functional gastrointestinal disorders, hepatic encephalopathy, and renal encephalopathy, as well as the clinical application of artificial intelligence in medical imaging. He has published 90 SCI papers (total citations: >3,249; h-index: 35; i10-index: 75; data source: Google Scholar, March 9, 2026). Among them, 50 SCI papers are as first author and/or corresponding author (including co-authorship), including 8 papers in the Chinese Academy of Sciences (CAS) Journal Ranking Q1 zone. The cumulative impact factor totals 216; 2 papers have an impact factor >10, and 13 papers have an impact factor >5.
Write to the Help Desk